A Study of ABT-751 in Patients With Renal Cell Cancer
Completed · Phase 2
Conditions studied: Renal Cell Cancer
In brief
The purpose of the study is to determine if ABT-751 will decrease tumors, and determine how long the tumor shrinkage can be maintained in patients with renal cell cancer. Patients will receive ABT-751 by mouth daily for 21 days. Patients will be off drug for 7 days before starting the next cycle of drug.
Key facts
- Study ID
- NCT00073112
- Run by
- Abbott
- People needed
- 60
- Starts
- 2003-08-01
- Expected to finish
- 2006-09-01
- Last updated by the study team
- 2007-11-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Renal Cell Carcinoma.
- Recurrent tumor.
- At least 6 weeks post-nephrectomy.
- Able to tolerate normal activities of daily living.
- Adequate bone marrow, kidney, and liver function.
You may not qualify if…
- Pregnant or breast feeding.
- Anti-tumor therapy within 4 weeks of the start of ABT-751 administration.
- CNS metastasis.
Where it is running
- Arizona Cancer Research Center — Tucson, Arizona, United States
- UCLA School of Medicine — Los Angeles, California, United States
- Clinical Trials + Research Associates — Montebello, California, United States
- US Oncology Inc Rocky Mountain Cancer Centers — Denver, Colorado, United States
- Oncology Hematology Group of South Florida — Miami, Florida, United States
- US Oncology Inc Florida Cancer Institute — New Port Richey, Florida, United States
- US Oncology Inc Ocala Oncology Center — Ocala, Florida, United States
- US Oncology Inc Cancer Centers of Florida, P.A. — Orlando, Florida, United States
- University of Chicago Medical Center — Chicago, Illinois, United States
- Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland, United States
- US Oncology Inc Raleigh Hematology Oncology Clinic — Cary, North Carolina, United States
- US Oncology Inc Dayton Oncology & Hematology P.A. — Kettering, Ohio, United States
- US Oncology Inc Cancer Care Accociates-Mercy Campus — Oklahoma City, Oklahoma, United States
- US Oncology Inc Cancer Centers of the Carolinas — Greenville, South Carolina, United States
- West Cancer Clinic — Memphis, Tennessee, United States
- Vanderbilt Ingram Cancer Center — Nashville, Tennessee, United States
- US Oncology Inc Tyler Cancer Center — Tyler, Texas, United States
- US Oncology Inc Cancer Care Northwest-North — Spokane, Washington, United States
- US Oncology Inc Northwest Cancer Specialists — Vancouver, Washington, United States
- B.C. Vancouver Cancer Agency — Vancouver, British Columbia, Canada
- Queen Elizabeth II Health Science Centre — Halifax, Nova Scotia, Canada
- McMaster University — Hamilton, Ontario, Canada
- McGill University — Montreal, Quebec, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.